Cascade Chemistry to boost U.S.-made API capacity

Sourcepharma manufacturing
Date Published02/19/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Cascade Chemistry
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Domestically, the work will be done:In-house
Capital investment ($):14
If relevant, work nearshored to:-
Product(s) reshoredactive pharmaceutical ingredients
What domestic positive factors made reshoring more attractive?Higher productivity, Under-utilized capacity, Other, import replacement
Find Reshoring Articles